Nanoparticulate clopidogrel and aspirin combination formulations

Details for Australian Patent Application No. 2006259606 (hide)

Owner Elan Pharma International, Limited

Inventors Jenkins, Scott; Liversidge, Gary G.

Agent Davies Collison Cave

Pub. Number AU-A-2006259606

PCT Pub. Number WO2006/138214

Priority 60/689,930 13.06.05 US

Filing date 12 June 2006

Wipo publication date 28 December 2006

International Classifications

A61K 31/4365 (2006.01)

A61K 31/60 (2006.01) - Salicylic acid

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

7 February 2008 PCT application entered the National Phase

  PCT publication WO2006/138214 Priority application(s): WO2006/138214

20 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006259609-Aspartyl protease inhibitors

2006259605-Ophthalmic and otorhinolaryngological device materials